Tag archive for ‘Orphan Drug’
Gil Tanenbaum On Wednesday, January 7th, 2015

Gamida Cell Gets FDA Orphan Drug Approval

Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that orphan drug designation has been granted by the FDA for its investigational More...

Gil Tanenbaum On Monday, December 22nd, 2014

Can-Fite Treats First Patient with New Cancer Drug

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, treated the first patient with its CF 102 in a Phase More...

Can-Fite is part of Israel startup nation
Gil Tanenbaum On Wednesday, October 1st, 2014

Can-Fite BioPharma Liver Drug Gets US Patent

Israel’s Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has received a patent in the US for its More...

Jewish Business News On Thursday, July 24th, 2014

Infections treatment co Atox Bio raises $23 million

– Atox Bio will conduct a Phase II study for a soft tissue infections treatment. Atox Bio, which develops therapeutics for severe infections, has raised up to $23 million in a Series E investment More...

Wordpress site Developed by Fixing WordPress Problems